Peptidergic Neural Cells are neurons that use peptides as neurotransmitters to transmit signals within the nervous system. Unlike classic neurotransmitters like acetylcholine or serotonin, which are small molecules, peptides are larger molecules composed of amino acids. Peptidergic neurons are involved in diverse physiological processes, including pain modulation, stress response, and regulation of appetite. These neural cells synthesize and release neuropeptides, which act as signaling molecules to modulate the activity of other neurons, glands, or organs. Examples of neuropeptides include substance P, enkephalins, and neuropeptide Y. Each neuropeptide can have specific effects on target cells, influencing processes such as pain perception, mood, and appetite regulation. Peptidergic neural cells are found throughout the central and peripheral nervous systems. In the brain, they play crucial roles in the regulation of emotions, behavior, and responses to stress. In the peripheral nervous system, peptidergic neurons are involved in the modulation of sensory information, gastrointestinal functions, and immune responses. Research on peptidergic neural cells is significant for understanding the complexities of neural signaling and its impact on various physiological functions. Dysregulation of peptidergic systems has been implicated in conditions such as chronic pain, mood disorders, and metabolic disorders. Technological advancements, including molecular imaging and genetic tools, enable scientists to study peptidergic neural cells with greater precision. Targeting these cells and their associated neuropeptides holds promise for developing therapeutic interventions for disorders related to neural signaling and neuromodulation. In summary, peptidergic neural cells form a diverse and important component of the nervous system, utilizing neuropeptides as neurotransmitters to regulate various physiological functions. Exploring the intricacies of peptidergic signaling contributes to our understanding of neural communication and opens avenues for potential therapeutic interventions in neural and endocrine disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States